PCRX
Pacira BioSciences, Inc.
24.70$
+2.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +26.0% | +11.0% | +3.7% | +17.7% | +24.8% | +2.0% | +26.0% | +23.1% | +1.2% | +3.9% | +3.6% | |
| – | -7.2% | +53.3% | -20.2% | -1.2% | +22.9% | +9.9% | +19.5% | +42.1% | -7.3% | -7.7% | -12.1% | |
| – | +47.4% | -6.1% | +19.5% | +26.0% | +25.5% | -0.6% | +28.5% | +16.5% | +4.9% | +8.2% | +8.7% | |
| – | +53.0% | +59.4% | +25.4% | -2.8% | +29.5% | -17.6% | -6.5% | +52.7% | -10.1% | +7.0% | +43.8% | |
| – | +47.2% | +3.4% | +5.2% | +5.2% | +1.4% | +5.2% | +18.0% | +24.0% | +6.3% | +4.9% | +16.4% | |
| – | +33.7% | +18.2% | +10.3% | +6.5% | +30.4% | -12.5% | +17.1% | +30.9% | -1.2% | +50.0% | -10.0% | |
| – | – | -438.7% | – | – | -34.2% | +342.3% | +94.0% | -33.3% | +46.1% | -183.7% | – | |
| – | -6.7% | -8.6% | +155.6% | +21.6% | +7.6% | +8.6% | +13.0% | +22.7% | -51.3% | -4.3% | -11.8% | |
| – | – | -1,885.1% | – | – | – | – | +180.8% | -76.4% | +363.8% | -202.3% | – | |
| – | +52.6% | -60.2% | +33.3% | -67.1% | +482.6% | -46,903.7% | – | -118.1% | – | +84.6% | -73.0% | |
| – | – | -2,144.7% | – | – | – | – | -71.2% | -62.1% | +163.7% | -337.3% | – | |
| – | +320.0% | -183.5% | – | – | -7.0% | +106.5% | +79.4% | +23.2% | +10.1% | -81.2% | +320.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.